Search Results - "PRESTIGIO Study Group"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.

    Authors: Castagna, Antonella Ferrara, Micol Galli, Laura et al.

    Source: Journal of Antimicrobial Chemotherapy (JAC). Jan2018, Vol. 73 Issue 1, p177-182. 6p. 2 Charts, 2 Graphs.

    Save to List
  2. 2

    Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry.

    Authors: Lagi F Bellomo M Lolatto R et al.

    Source: Viruses [Viruses] 2025 Aug 24; Vol. 17 (9). Date of Electronic Publication: 2025 Aug 24.

    Publication Type: Journal Article

    Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List

Search Tools: